‹ Back

 

Our Team at AD/PD™ 2025 in Vienna – A Key Moment for Neurodegenerative Disease Research

From April 1st to 5th, 2025, our team from the CHUV Unit of Neurobiology of Aging (#RichetinLab) had the honor of actively participating in the AD/PD™ 2025 international conference, which brought together leading experts in Alzheimer’s disease, Parkinson’s disease, and related neurodegenerative disorders.

 

Held in Vienna in a hybrid format, this special edition marked the 40th anniversary of the AD/PD™ conference—a milestone event showcasing the latest translational advances in biomarkers, neuroimaging, pathophysiology, and emerging therapeutic approaches.

Our team contributed several scientific presentations:

 

Kevin Richetin
→ On-demand oral communication + poster
“Proteomic analysis of cortex-derived extracellular vesicles in the context of tauopathies”
A detailed investigation into cortex-derived extracellular vesicles in tauopathy models.
Presented on April 4 & 5, 2025.

 

 

Aatmika Barve
→ Oral presentation in a symposium
“Potential plasma biomarkers of blood-brain barrier dysfunction for detecting Alzheimer's disease with cerebral amyloid angiopathy”
A pioneering study on plasma biomarkers reflecting blood-brain barrier dysfunction.
Presented on April 4, 2025 | 16:20 – 18:20 | Room E.

 

Valentin Zufferey
→ Poster
“Divergent consequences of extracellular tau on the mitochondrial function of astrocytes and neurons”
A study highlighting the cell-type-specific mitochondrial effects of extracellular tau.
Presented on April 5, 2025.

 

 

Luc N. Belinga
→ On-demand oral communication + poster
“Isoform-specific tau drives distinct neural disruptions and behaviors in behavioral variant frontotemporal dementia”
A mechanistic approach to understanding tau isoform-specific pathology in bvFTD.
Presented on April 2 & 3, 2025.

 

Beyond the scientific presentations, AD/PD™ 2025 was a rich opportunity for high-level exchanges, impactful networking, and the development of new international collaborations—particularly around cohort diversity, multimodal research, and technology transfer toward low- and middle-income countries.

 

For more information about the conference and the presented abstracts:

➡️ Official AD/PD™ 2025 website

 

Congratulations to the entire team for your commitment and the scientific visibility achieved. We look forward to continuing this momentum and exploring what comes next in neuroscience research.